Dr. Yair Schindel, aMoon Managing Partner, on Covid-19 and Investing in Medtech

Dr. Yair Schindel

When VC aMoon was established in 2017, “the premise was to invest heavily in the convergence of technology and biology, healthcare and data,” says Dr. Yair Schindel, its Managing Partner. Schindel and Marius Nacht, the other founder of the Israeli venture capital firm which has raised to date more than $1 billion, were talking to potential investors about “the coming tsunami of healthtech” over the next 10 years. “Now we see things happening that we only expected to see three or five years from now,” says Schindel. “In that sense, Covid put everything on steroids.”

Read more here